Silver Book Fact

Diabetes drug expenditures rose from $6.7 billion in 2001 to $12.5 billion in 2007.

Alexander G, Sehgal N, Moloney R, Stafford R. National Trends in Treatment of Type 2 Diabetes Mellitus, 1994-2007. Arch Intern Med. 2008; 168(19): 2088-94. http://archinte.jamanetwork.com/article.aspx?articleid=773439

Reference

Title
National Trends in Treatment of Type 2 Diabetes Mellitus, 1994-2007
Publication
Arch Intern Med
Publication Date
2008
Authors
Alexander G, Sehgal N, Moloney R, Stafford R
Volume & Issue
Volume 168, Issue 19
Pages
2088-94
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • 44,400 diabetics began treatment for end-stage renal disease (ESRD) in 2002.  
  • Indirect costs of diabetes include increased absenteeism ($2.6 billion) and reduced productivity while at work ($20.0 billion) for the employed population, reduced productivity for those not in the labor force…  
  • Medicare beneficiaries with diabetic macular edema (DME) had 31% higher 1-year costs and 29% higher 3-year costs compared to diabetic Medicare beneficiaries without DME.  
  • Death rates are 1.5 times higher in adults with diabetes, than in adults without the disease.  
  • In 2004, heart disease was noted on 68% of diabetes-related death certificates among Americans aged 65 and older.